Holdings
Sarissa Capital Management LP
As of Sep 30, 2026, Sarissa Capital Management LP reported 10 positions worth US$153M. Largest: Innoviva, Inc., Ironwood Pharmaceuticals, Inc. and Amarin Corporation plc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Innoviva, Inc. | 1.89M | US$40.1M | no change | Sep 30, 2026 |
| Ironwood Pharmaceuticals, Inc. | 9.19M | US$36.5M | no change | Sep 30, 2026 |
| Amarin Corporation plc | 1.29M | US$16.7M | new | Sep 30, 2026 |
| Lantheus Holdings, Inc. | 167K | US$16.6M | no change | Sep 30, 2026 |
| Neurocrine Biosciences, Inc. | 117K | US$16.5M | no change | Sep 30, 2026 |
| Cytokinetics, Incorporated | 229K | US$15.1M | no change | Sep 30, 2026 |
| Biohaven Ltd. | 582K | US$7.77M | no change | Sep 30, 2026 |
| Regeneron Pharmaceuticals, Inc. | 4,190 | US$3.18M | no change | Sep 30, 2026 |
| Vor Biopharma Inc. | 25,399 | US$485K | no change | Sep 30, 2026 |
| Biogen Inc. | 950 | US$215K | no change | Sep 30, 2026 |